EUVIMEDEUVIMED entdecken
Crossref

In vitro and in silico evaluation of psilocybin and psilocin’s interaction with CYP450 enzymes

Machado Brito-Da-Costa, Andreia, Carvalho, Mariana, Ricardo Jorge Dinis‐Oliveira, Áurea Madureira-Carvalho, F. Sousa, Sérgio, Dias Da Silva, Diana

Science Letters · 29.04.2024

DOI: 10.48797/sl.2024.236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 29.04.2024. Verfasst von Machado Brito-Da-Costa und 9 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psilocybin is a hallucinogen produced by “magic mushrooms”, being rapidly metabolized in the organism into psilocin [1, 2]. A scientific gap exists regarding the possible interactions between psilocybin/psilocin and CYP450 enzymes. Given their biological importance, and since the binding of drugs to CYP450 enzymes can interfere with the metabolism of other substrates leading to drug-drug interactions, this research topic is of utmost importance.

Objective

This study aimed to evaluate in silico and in vitro the interaction of psilocybin and psilocin with the enzymes CYP2A6/2B6/2D6/2E1/3A4.

Methods

The in vitro assessment of inhibition was performed using the Vivid®CYP450 screening kits. IC50 was calculated using GraphPad Prism 9.3.0. For in silico assessment, molecular dynamics were performed using the PMEMD.cuda module in AMBER16. Calculations were made on the last 100 ns of the trajectory (stable zone) to assess the interaction between enzyme and ligand, namely MMGBSA, per-residue decomposition energy, and hydrogen bonds.

Results

Psilocin showed the capacity to be an inhibitor of CYP2A6/2B6/2D6/2E1/3A4, based on the respective IC50 values (mM) of 2.06, 6.17, 11.89, 6.37, and 2.36. Considering the MMGBSA, higher values were obtained for psilocin, corroborating the stronger binding affinity of this compound. The interaction of psilocybin/psilocin with CYP2A6 is mediated by a hydrogen bond established with the protein residue Asn297. Other important residues include Phe107 and Ile366. For CYP2B6, the strong binding of psilocin is mediated by interactions with Ile114, Thr302 (hydrogen bond), and Leu363. For interaction with CYP2D6, the most important residue seems to be Ser304, with which it forms a hydrogen bond; for CYP2E1, key residues include Phe207, Thr303, and Phe478. A strong hydrogen bond is formed between psilocin and CYP3A4 residue Phe304, contributing to the high binding affinity.

Conclusions

The results suggest a potential for psilocin to inhibit all enzymes, especially CYP2A6 and CYP3A4.

Schlagwörter

psilocybinpsilocincytochrome P450drug-drug interactionsenzyme inhibitionCYP2A6CYP2B6CYP2D6CYP2E1CYP3A4

Zitieren

APA

Brito-Da-Costa, M., Andreia, Carvalho, Mariana, Dinis‐Oliveira, R. J., Madureira-Carvalho, Á., Sousa, F., Sérgio, Silva, D. D., & Diana (2024). In vitro and in silico evaluation of psilocybin and psilocin’s interaction with CYP450 enzymes. Science Letters. https://doi.org/10.48797/sl.2024.236

Vancouver

Brito-Da-Costa M, Andreia, Carvalho, Mariana, Dinis‐Oliveira RJ, Madureira-Carvalho Á, et al. In vitro and in silico evaluation of psilocybin and psilocin’s interaction with CYP450 enzymes. Science Letters. 2024. doi:10.48797/sl.2024.236

BibTeX
@article{BritoDaCosta2024,
  author = {Brito-Da-Costa, Machado and Andreia and Carvalho and Mariana and Dinis‐Oliveira, Ricardo Jorge and Madureira-Carvalho, Áurea and Sousa, F. and Sérgio and Silva, Dias Da and Diana},
  title = {In vitro and in silico evaluation of psilocybin and psilocin’s interaction with CYP450 enzymes},
  journal = {Science Letters},
  year = {2024},
  doi = {10.48797/sl.2024.236}
}
Kostenlos starten →